These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects on growth hormone secretion following intravenous and subcutaneous injections of growth hormone-releasing factor (hGRF-44 NH2): comparison of immunoreactive plasma GRF levels. Sassolas G; Biot-Laporte S; Cohen R; Elm Charfi A; Ferry S; Borson F Clin Endocrinol (Oxf); 1985 May; 22(5):645-53. PubMed ID: 3928209 [TBL] [Abstract][Full Text] [Related]
4. Characterization by high-performance liquid chromatography of circulating growth hormone-releasing factors in normal subjects. Penny ES; Sopwith AM; Patience RL; Wass JA; Besser GM; Rees LH J Endocrinol; 1986 Dec; 111(3):507-11. PubMed ID: 3100712 [TBL] [Abstract][Full Text] [Related]
5. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion. Vance ML; Kaiser DL; Evans WS; Furlanetto R; Vale W; Rivier J; Thorner MO J Clin Invest; 1985 May; 75(5):1584-90. PubMed ID: 2860126 [TBL] [Abstract][Full Text] [Related]
6. Characterisation by high performance liquid chromatography of circulating growth hormone releasing factors in a human plasma. Penny ES; Patience RL; Sopwith AM; Wass JA; Besser GM; Rees LH J Endocrinol; 1985 Apr; 105(1):R1-R4. PubMed ID: 3921640 [TBL] [Abstract][Full Text] [Related]
7. Immunoreactive growth hormone-releasing hormone (IR-GHRH) in the feto-placental circulation and differential effects of L-dopa, L-arginine and somatostatin-14 on the plasma levels of IR-GHRH in normal adults. Saito H; Hosoi E; Yamasaki R; Kameyama K; Irahara M; Ohno Y; Saito S Horm Metab Res; 1997 Apr; 29(4):184-9. PubMed ID: 9178029 [TBL] [Abstract][Full Text] [Related]
8. Restoration of juvenile baseline growth hormone secretion with preservation of the ultradian growth hormone rhythm by continuous delivery of growth hormone-releasing factor. Vasilatos-Younken R; Tsao PH; Foster DN; Smiley DL; Bryant H; Heiman ML J Endocrinol; 1992 Nov; 135(2):371-82. PubMed ID: 1474343 [TBL] [Abstract][Full Text] [Related]
15. Tissue distribution and molecular heterogeneity of human growth hormone-releasing factor in the transgenic mouse. Frohman LA; Downs TR; Kashio Y; Brinster RL Endocrinology; 1990 Nov; 127(5):2149-56. PubMed ID: 2226307 [TBL] [Abstract][Full Text] [Related]
16. Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly. Penny ES; Penman E; Price J; Rees LH; Sopwith AM; Wass JA; Lytras N; Besser GM Br Med J (Clin Res Ed); 1984 Aug; 289(6443):453-5. PubMed ID: 6432140 [TBL] [Abstract][Full Text] [Related]
17. Presence of growth hormone-releasing factor-like immunoreactivity in human cerebrospinal fluid. Kashio Y; Chihara K; Kaji H; Minamitani N; Kita T; Okimura Y; Abe H; Iwasaki J; Fujita T J Clin Endocrinol Metab; 1985 Feb; 60(2):396-8. PubMed ID: 3917461 [TBL] [Abstract][Full Text] [Related]
18. Suppression of human growth hormone (GH)-releasing hormone-induced GH secretion in pentobarbital-anesthetized rats after electrical stimulation of the midbrain central gray and several raphe nuclei. Koibuchi N; Kato M; Kakegawa T; Suzuki M Endocrinology; 1988 Feb; 122(2):659-64. PubMed ID: 3123202 [TBL] [Abstract][Full Text] [Related]